Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Buckner JC, Schomberg PJ, McGinnis WL, Cascino TL, Scheithauer BW, O'Fallon JR, Morton RF, Kuross SA, Mailliard JA, Hatfield AK, Cole JT, Steen PD, Bernath AM. Buckner JC, et al. Among authors: hatfield ak. Cancer. 2001 Jul 15;92(2):420-33. doi: 10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3. Cancer. 2001. PMID: 11466698 Clinical Trial.
Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R. Jett JR, et al. Among authors: hatfield ak. Cancer. 2003 May 15;97(10):2498-503. doi: 10.1002/cncr.11377. Cancer. 2003. PMID: 12733149 Free article. Clinical Trial.
Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: a North Central Cancer Treatment Group Study.
Edmonson JH, Suman VJ, Dalton RJ, Bro WC, Gallenberg MM, Long HJ, Levitt R, Hatfield AK, Krook JE, Mailliard JA, Gerstner JB; North Central Cancer Treatment Group. Edmonson JH, et al. Among authors: hatfield ak. Cancer Invest. 2001;19(6):597-602. doi: 10.1081/cnv-100104287. Cancer Invest. 2001. PMID: 11486702 Clinical Trial.
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
Burch PA, Block M, Schroeder G, Kugler JW, Sargent DJ, Braich TA, Mailliard JA, Michalak JC, Hatfield AK, Wright K, Kuross SA. Burch PA, et al. Among authors: hatfield ak. Clin Cancer Res. 2000 Sep;6(9):3486-92. Clin Cancer Res. 2000. PMID: 10999733 Clinical Trial.
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Ingle JN, Foley JF, Mailliard JA, Krook JE, Hartmann LC, Jung SH, Veeder MH, Gesme DH Jr, Hatfield AK, Goldberg RM. Ingle JN, et al. Among authors: hatfield ak. Cancer. 1994 May 1;73(9):2337-43. doi: 10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co;2-q. Cancer. 1994. PMID: 8168039 Clinical Trial.
A randomized trial of interferon-alpha in cervical dysplasia.
Gostout BS, Hartmann LC, Suman VJ, Fay NE, Jefferies JA, Morton RF, Gaffey TA, Farr GH Jr, Tschetter LK, Abu-Ghazaleh S, Gallenberg MM, Hatfield AK. Gostout BS, et al. Among authors: hatfield ak. Int J Gynaecol Obstet. 2001 Aug;74(2):207-10. doi: 10.1016/s0020-7292(00)00389-1. Int J Gynaecol Obstet. 2001. PMID: 11502303 Clinical Trial. No abstract available.
46 results